ClassID:

21647

A61K2300/00 - page 40 - CPC Classification

Classification description:

Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups  - 

Recent Application in this class:
#11701
20100172845
2010-07-08

COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIAL INFECTIONS

#11702
20100172822
2010-07-08

Use of sodium selenosulfate for supplementing selenium and enhancing the therapeutic efficacy of chemotherapy agents, and a rapid process for preparing sodium selenosulfate

#11703
20100170849
2010-07-08

BUFFERED COMPOSITIONS FOR DIALYSIS

#11704
20100168900
2010-07-01

Systems, devices, and methods for making or administering frozen particles

#11705
20100168246
2010-07-01

AMINE COMPOUNDS AND INHIBITING NEUROTRANSMITTER REUPTAKE

#11706
20100168241
2010-07-01

TREATMENT OF ACNE DISEASE STATES, NOTABLY ACNE VULGARIS

#11707
20100168239
2010-07-01

Use of rasagiline for the treatment of multiple system atrophy

#11708
20100168238
2010-07-01

Pharmaceutical composition containing phloroglucinol and paracetamol

#11709
20100168220
2010-07-01

PLANT EXTRACT COMPOSITION FOR TREATING HEPATITIS C

#11710
20100168187
2010-07-01

THERAPEUTIC COMBINATION

#11711
20100168186
2010-07-01

Pre-mixed, ready-to-use pharmaceutical compositions

#11712
20100168174
2010-07-01

Combination of AMPA Receptor Antagonists and Acetylcholinesterase Inhibitors for the Treatment of Neuropathic Pain

#11713
20100168166
2010-07-01

Method of Providing An Antihistaminic Effect in a Hepatically Impaired Patient

#11714
20100168152
2010-07-01

Fat regulation

#11715
20100168147
2010-07-01

Medicinal Compositions Comprising Buprenorphine And Naloxone

#11716
20100168137
2010-07-01

COMBINATION FOR USE IN THE TREATMENT OF INFLAMMATORY DISORDERS

#11717
20100168133
2010-07-01

USE OF SUBSTITUTED QUINOLINE DERIVATIVES FOR THE TREATMENT OF DRUG RESISTANT MYCOBACTERIAL DISEASES

#11718
20100168119
2010-07-01

COMPOSITIONS AND METHODS FOR MINIMIZING OR REDUCING AGONIST-INDUCED DESENSITIZATION

#11719
20100168115
2010-07-01

Use of triazine derivatives for the manufacture of a medicament having a cicatrising or angiogenic effect

#11720
20100168113
2010-07-01

Pharmaceutical compounds

#11721
20100168086
2010-07-01

7,8,10,10A-TETRAHYDRO-6H-BENZO[C]CHROMEN-9(6AH)-ONE MODULATORS OF CANNABINOID RECEPTORS

#11722
20100168085
2010-07-01

Dopamine and agonists and antagonists thereof for modulation of suppressive activity of CD4+CD25+ regulatory T cells

#11723
20100168084
2010-07-01

Therapeutic compounds and related methods of use

#11724
20100168082
2010-07-01

Heterobicyclic carboxamides as inhibitors for kinases

#11725
20100168072
2010-07-01

Drug Combinations for the Treatment of Duchenne Muscular Dystrophy

#11726
20100168071
2010-07-01

EXTENDED ESTROGEN DOSING CONTRACEPTIVE REGIMEN

#11727
20100168053
2010-07-01

ORAL DELIVERY SYSTEM FOR METHYLCOBALAMIN TO TREAT DISORDERS

#11728
20100168052
2010-07-01

Treatment of EBV and KHSV Infection and Associated Abnormal Cellular Proliferation

#11729
20100168046
2010-07-01

METHODS OF USING [3.2.0] HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF FOR TREATING INFECTIOUS DISEASES

#11730
20100168025
2010-07-01

Treatment of stroke using domain V of perlecan

#11731
20100168012
2010-07-01

HUMAN CANCER THERAPY USING ENGINEERED MATRIX METALLOPROTEINASE-ACTIVATED ANTHRAX LETHAL TOXIN THAT TARGETS TUMOR VASCULATUTURE

#11732
20100168004
2010-07-01

Methods and compositions for the synergistic activation of latent HIV

#11733
20100167990
2010-07-01

Pharmaceutical formulations comprising an insulin derivative

#11734
20100167989
2010-07-01

ISOPROPOXYPHENYLMETHYL INHIBITORS OF SGLT2

#11735
20100167988
2010-07-01

ETHOXYPHENYLMETHYL INHIBITORS OF SGLT2

#11736
20100167987
2010-07-01

Methods and pharmaceutical compositions for healing wounds

#11737
20100167983
2010-07-01

Combination therapy with glatiramer acetate and rasagiline for the treatment of multiple sclerosis

#11738
20100167265
2010-07-01

VACCINE AGAINST INFECTIOUS AGENTS HAVING AN INTRACELLULAR PHASE, COMPOSITION FOR THE TREATMENT AND PREVENTION OF HIV INFECTIONS, ANTIBODIES AND METHOD OF DIAGNOSIS

#11739
20100167261
2010-07-01

PLATELET STABILIZATION

#11740
20100166918
2010-07-01

Nutraceuticals containing nitro fatty acids

#11741
20100166893
2010-07-01

Herbal composition for reducing ADD/ADHD and method thereof

#11742
20100166892
2010-07-01

Herbal composition PHY906 and its use in chemotherapy

#11743
20100166891
2010-07-01

Composition comprising hemp oil for treating topical diseases, especially hand-foot syndrome

#11744
20100166888
2010-07-01

Composition and method for the control of organoleptic properties of bodily fluids and secretions

#11745
20100166887
2010-07-01

DIBENZO[b,e][1,4]DIAZEPINE MODULATORS OF DOPAMINE RECEPTORS, SEROTONIN RECEPTORS, ADRENERGIC RECEPTORS, ACETYLCHOLINE RECEPTORS, AND/OR HISTAMINE RECEPTORS

#11746
20100166886
2010-07-01

METHODS OF TREATING THE SKIN

#11747
20100166884
2010-07-01

Potentiation of cancer chemotherapy by 7-(2, 5-dihydro-4-imidazo [1, 2-A] pyridine-3-yl-2,5-Dioxo-1H-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro-2-(1-piperidinyl-carbonyl)-pyrrolo [3,2,1-jk] [1,4] benzodiazepine

#11748
20100166883
2010-07-01

Compositions for accelerating the production of collagen-containing proteins

#11749
20100166882
2010-07-01

Composition comprising egg white combined chalcanthite for preventing or treating cancer

#11750
20100166869
2010-07-01

METHODS AND COMPOSITIONS FOR TREATING PULMONARY HYPERTENSION

#11751
20100166867
2010-07-01

Administration form of osteogenic protein complexes

#11752
20100166860
2010-07-01

Medicine for treating gastrointestinal disorder including acquired lactose-intolerance irritable bowel syndrome

#11753
20100166856
2010-07-01

PHARMACEUTICAL COMPOSITION IN THE FORM OF COATED MICROSPHERES FOR THE MODIFIED RELEASE OF A MUSCLE RELAXANT AND AN NSAID

#11754
20100166848
2010-07-01

LIPOSOMAL FORMULATIONS FOR TREATING CANCER

#11755
20100166846
2010-07-01

MANAGEMENT OF MYOCLONUS WITH ORAL LIPOSOMAL REDUCED GLUTATHIONE

#11756
20100166824
2010-07-01

EXTRACELLULAR MATRIX COMPOSITIONS

#11757
20100166807
2010-07-01

Methods for reducing the incidence of mastitis

#11758
20100166799
2010-07-01

Adenoviral vectors and methods and uses related thereto

#11759
20100166782
2010-07-01

CLIP INHIBITORS AND METHODS OF MODULATING IMMUNE FUNCTION

#11760
20100166778
2010-07-01

Toll-like receptor 3 antagonists

#11761
20100166776
2010-07-01

Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors

#11762
20100166768
2010-07-01

High affinity human antibodies to PCSK9

#11763
20100166745
2010-07-01

Transferrin receptor antibodies

#11764
20100166736
2010-07-01

Immunostimulatory oligonucleotide multimers

#11765
20100166735
2010-07-01

METHODS AND COMPOSITIONS FOR REDUCTION OF SIDE EFFECTS OF THERAPEUTIC TREATMENTS

#11766
20100166730
2010-07-01

Liquid, Aqueous Pharmaceutical Composition of Factor VII Polypeptides

#11767
20100166729
2010-07-01

Modified factor VII polypeptides and uses thereof

#11768
20100166727
2010-07-01

S-Adenosylmethionine And Methylthioadensosine In Chemoprevention And Treatment Of Colon Polyps And Cancer

#11769
20100166715
2010-07-01

Methods for obtaining a therapeutically effective amount of hematopoietic precursor cells and long term engraftment thereof

#11770
20100166701
2010-07-01

METHOD FOR TREATING RENAL CELL CARCINOMA USING GLYCOGENOLYSIS INHIBITORS

#11771
20100166699
2010-07-01

Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators

#11772
20100166698
2010-07-01

NEW COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATION

#11773
20100166697
2010-07-01

Method of treating cancer by combination therapy using TNF and alpha-galactosylceramide

#11774
20100166696
2010-07-01

AMIDO-AMINE DENDRIMER COMPOSITIONS

#11775
20100166675
2010-07-01

Method of ameliorating symptoms of type 1-diabetes using GABA related compounds and GLP-1/exendin-4 compounds

#11776
20100166671
2010-07-01

ORGANIC COMPOUNDS

#11777
20100166649
2010-07-01

Method to inhibit cancer targeting CD24

#11778
20100163576
2010-07-01

Systems, devices, and methods for making or administering frozen particles

#11779
20100160445
2010-06-24

Synergistic Mixtures of OPP and DGH

#11780
20100160431
2010-06-24

Methods and Compositions for the Treatment of Viral Infections

#11781
20100160429
2010-06-24

Anti-bacterial plant compositions

#11782
20100160427
2010-06-24

METHOD OF TREATING VASCULAR INJURIES INDUCED BY AN EXCESS OF PLASMA LIPIDS USING COMBINATIONS OF VASOPROTECTIVE AGENTS

#11783
20100160402
2010-06-24

Bisbenzimidazoles as antimalarial agents

#11784
20100160372
2010-06-24

TREATMENT OF PROTEINOPATHIES USING A FARNESYL TRANSFERASE INHIBITOR

#11785
20100160367
2010-06-24

PHARMACEUTICAL COMPOSITIONS CONTAINING PYRROLOQUINOLINE QUINONE AND NEPHROPROTECTANT FOR TREATING ISCHEMIA REPERFUSION INJURIES

#11786
20100160366
2010-06-24

TREATMENT METHOD

#11787
20100160361
2010-06-24

TREATMENT OF MAJOR ADVERSE CARDIAC EVENTS AND ACUTE CORONARY SYNDROME USING SECRETORY PHOSPHOLIPASE A2 (SPLA2) INHIBITOR OR SPLA2 INHIBITOR COMBINATION THERAPIES

#11788
20100160351
2010-06-24

PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING HYPERURICEMIA AND RELATED DISORDERS

#11789
20100160343
2010-06-24

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

#11790
20100160341
2010-06-24

Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4

#11791
20100160298
2010-06-24

Method of treating ocular allergy

#11792
20100160295
2010-06-24

TREATMENT OF RESTLESS LEG SYNDROME AND SLEEP DISORDERS

#11793
20100160294
2010-06-24

TOLERABILITY OF MIRTAZAPINE AND A SECOND ACTIVE BY USING THEM IN COMBINATION

#11794
20100160290
2010-06-24

Pharmaceutical composition for treating Alzheimer's disease

#11795
20100160284
2010-06-24

Carbapenem antibacterials with gram-negative activity and processes for their preparation

#11796
20100160277
2010-06-24

Compositions for combating beta-lactamase-medicated antibiotic resistance using beta-lactamase inhibitors useful for injection

#11797
20100160273
2010-06-24

Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues

#11798
20100160270
2010-06-24

Use of testosterone and a 5-HT1a agonist in the treatment of sexual dysfunction

#11799
20100160257
2010-06-24

Use of HDAC inhibitors for the treatment of myeloma

#11800
20100160240
2010-06-24

Treatment for epilepsy

#11801
20100160233
2010-06-24

ANTITUMOUR COMBINATIONS CONTAINING A VEGF INHIBITING AGENT AND IRINOTECAN

#11802
20100160223
2010-06-24

Synergetic Effects of HGF and Antibacterial Treatment

#11803
20100160208
2010-06-24

Pharmaceutical composition

#11804
20100159041
2010-06-24

Combinations of herb extracts having synergistic antioxidant effect, and methods relating thereto

#11805
20100159040
2010-06-24

Synergistic antioxidant combinations of herb extracts and methods relating thereto

#11806
20100159036
2010-06-24

USE AS A MEANS TO IMPROVE FERTILITY OF A PHYTOTHERAPEUTIC COMPOSITION AND METHOD FOR IMPROVING AND/OR PROMOTING FERTILITY HEALTH

#11807
20100159035
2010-06-24

KIT FOR TREATING SKIN INFECTION

#11808
20100159034
2010-06-24

PYRROLIDINONE INHIBITORS OF PDE-4

#11809
20100159033
2010-06-24

BENZISOXAZOLE MODULATORS OF D2 RECEPTOR, AND/OR 5-HT2A RECEPTOR

#11810
20100159032
2010-06-24

COMBINATIONS USEFUL FOR THE TREATMENT OF NEURONAL DISORDERS

#11811
20100159031
2010-06-24

Nail fungus treatment and composition

#11812
20100159030
2010-06-24

METHODS FOR DETECTING AND MODULATING THE SENSITIVITY OF TUMOR CELLS TO ANTI-MITOTIC AGENTS AND FOR MODULATING TURMORGENICITY

#11813
20100159029
2010-06-24

COMPOSITION AND NUTRITIONAL SUPPLEMENTS FOR IMPROVING OCULAR HEALTH AND REDUCING OCULAR INFLAMMATORY RESPONSE

#11814
20100159026
2010-06-24

Colonic purgative composition with soluble binding agent

#11815
20100159021
2010-06-24

Small Molecule Ligands of the Integrin RGD Recognition Site and Methods of Use

#11816
20100159005
2010-06-24

COMBINATION OF TRIAZINE DERIVATIVES AND PPARalpha AGONISTS

#11817
20100159004
2010-06-24

METHODS AND COMPOSITIONS FOR REDUCTION OF SIDE EFFECTS OF THERAPEUTIC TREATMENTS

#11818
20100158999
2010-06-24

COMBINATION OF TRIAZINE DERIVATIVES AND HMG-COA REDUCTASE INHIBITORS

#11819
20100158987
2010-06-24

Adhesive Label With Bittering Agent and Fluidifying Agents for Natural Airway Secretions

#11820
20100158984
2010-06-24

Encapsulates

#11821
20100158972
2010-06-24

METHOD FOR REDUCING THE LIKELIHOOD OF PRETERM LABOR IN A SUBJECT IN NEED THEREOF

#11822
20100158971
2010-06-24

METHOD FOR REDUCING THE LIKELIHOOD OF PREECLAMPSIA IN A SUBJECT IN NEED THEREOF

#11823
20100158967
2010-06-24

SELENIUM-BASED BIOCIDAL FORMULATIONS AND METHODS OF USE THEREOF

#11824
20100158966
2010-06-24

SELENIUM-BASED BIOCIDAL FORMULATIONS AND METHODS OF USE THEREOF

#11825
20100158936
2010-06-24

Immunostimulatory compositions and methods

#11826
20100158920
2010-06-24

Fully human antibodies directed against the human insulin-like growth factor-1 receptor

#11827
20100158914
2010-06-24

KLOTHO BETA

#11828
20100158905
2010-06-24

COMBINATION THERAPY OF ARTHRITIS WITH TRANILAST

#11829
20100158897
2010-06-24

PAI-1 MODULATORS FOR THE TREATMENT OF OCULAR DISORDERS

#11830
20100158895
2010-06-24

METHODS AND COMPOSITIONS FOR REDUCTION OF SIDE EFFECTS OF THERAPEUTIC TREATMENTS

#11831
20100158887
2010-06-24

Direct application of non-toxic crosslinking reagents to resist progressive spinal degeneration and deformity

#11832
20100158885
2010-06-24

Therapeutic composition produced using punica granatum and hydrogen peroxide

#11833
20100158861
2010-06-24

Treating idiopathic thrombocytopenic purpura with comprising extracts of

#11834
20100158858
2010-06-24

ADMINISTRATION OF CARBOLINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISEASES

#11835
20100158850
2010-06-24

DENDRIMER BASED MODULAR PLATFORMS

#11836
20100152880
2010-06-17

Systems, devices and methods for making or administering frozen particles

#11837
20100152651
2010-06-17

Frozen compositions and methods for piercing a substrate

#11838
20100152305
2010-06-17

Methods of treatment of hyperuricemia and associated disease states

#11839
20100152285
2010-06-17

Flavononol Renin Inhibitor Compounds and Methods of Use Thereof

#11840
20100152275
2010-06-17

Drug or Supplement Combination with Conjugated Linoleic Acid for Fat Loss in Mammals

#11841
20100152271
2010-06-17

Estrogen receptor modulators and uses thereof

#11842
20100152268
2010-06-17

STABLE ATORVASTATIN FORMULATIONS

#11843
20100152263
2010-06-17

Compositions and methods for the treatment of overactive bladder

#11844
20100152262
2010-06-17

BUCCAL, POLAR AND NON-POLAR SPRAY CONTAINING ONDANSETRON

#11845
20100152222
2010-06-17

Medicinal compositions comprising buprenorphine and nalmefene

#11846
20100152221
2010-06-17

Pharmaceutical composition

#11847
20100152198
2010-06-17

USE OF C-SRC INHIBITORS IN COMBINATION WITH A PYRIMIDYLAMINOBENZAMIDE COMPOUND FOR THE TREATMENT OF LEUKEMIA

#11848
20100152161
2010-06-17

COMPOSITIONS FOR WEIGHT MANAGEMENT

#11849
20100152145
2010-06-17

Use of 3-alpha-androstanediol in combination with a PDE5 inhibitor, in the treatment of sexual dysfunction

#11850
20100152143
2010-06-17

Methods of treating skin disorders with caffeic acid analogs

#11851
20100152133
2010-06-17

Use of chitosans to increase nail growth rate

#11852
20100152131
2010-06-17

Method for producing purified hematinic iron-saccharadic complex and product produced

#11853
20100152130
2010-06-17

TREATMENT OF CANCER WITH GLUTAMINE

#11854
20100152129
2010-06-17

Novel synergistic combination of gemcitabine with P276-00 or P1446A in treatment of cancer

#11855
20100152126
2010-06-17

Beta-L-2'-Deoxy-Nucleosides for the Treatment of Hepatitis B

#11856
20100152122
2010-06-17

Oligo-guluronate and galacturonate compositions

#11857
20100152108
2010-06-17

METHODS AND COMBINATION THERAPIES FOR TREATING ALZHEIMER'S DISEASE

#11858
20100152107
2010-06-17

LONG-TERM FEED - CANCER PATIENT

#11859
20100152100
2010-06-17

ACCELERATED THERAPY

#11860
20100151492
2010-06-17

Methods for the treatment of infections and tumors

#11861
20100151066
2010-06-17

COMPOSITION FOR SUPPRESSING APPETITE, IMPROVING TONE AND MOOD, WITH A NATURAL ANTIDEPRESSANT ACTIVITY AND WITH AN ANTIASTHENIC EFFECT

#11862
20100151061
2010-06-17

METHODS OF USING BENFOTIAMINE AND PYRIDOXAMINE COMPOSITIONS

#11863
20100151058
2010-06-17

Compositions for producing satiety

#11864
20100151051
2010-06-17

Anti-tumor drug, medicament, composition, and use thereof

#11865
20100151048
2010-06-17

Topical composition and method for the treatment and prophylaxis of dermal irritations

#11866
20100151045
2010-06-17

COMPOSITION AND METHOD FOR REDUCING SIDE-EFFECTS OF INDOLE-3-CARBINOL AND DERIVATIVES

#11867
20100151044
2010-06-17

USE OF ISOOSMOTIC SEAWATER-BASED IONIC SOLUTIONS FOR MANUFACTURING MEDICAL DEVICES FOR THE PREVENTION OF COMPLICATIONS OF THE COMMON COLD OR OF THE FLU SYNDROME

#11868
20100151042
2010-06-17

Materials and Methods for Treating Influenza Infections

#11869
20100151032
2010-06-17

Silver and Zinc Containing Body Care Agent

#11870
20100151025
2010-06-17

PREVENTION AND TREATMENT FOR OSTEONECROSIS AND OSTEORADIONECROSIS OF THE JAW

#11871
20100151023
2010-06-17

Time delayed release mechanism for energizing composition and method of use

#11872
20100151013
2010-06-17

Gastric acid secretion inhibiting composition

#11873
20100151006
2010-06-17

Cancer therapy sensitizer

#11874
20100151004
2010-06-17

MODULATION OF DRUG SENSITIVITY

#11875
20100150997
2010-06-17

Treatment of arthritis with parathyroid hormone

#11876
20100150996
2010-06-17

ATHLETIC PATCH

#11877
20100150986
2010-06-17

Film preparation with rapidly dissolving property and flexibility

#11878
20100150974
2010-06-17

Oral care product

#11879
20100150970
2010-06-17

Administration of Enoxoparin Sodium to Patients 75 Years and Older With ST-Segment Elevation Myocardian Infarction

#11880
20100150947
2010-06-17

TOLERANCE INDUCTION AND MAINTENANCE IN HEMATOPOIETIC STEM CELL ALLOGRAFTS

#11881
20100150944
2010-06-17

METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF DEPRESSION AND ANXIETY

#11882
20100150940
2010-06-17

Anti-IGF antibodies

#11883
20100150936
2010-06-17

Method of treating rash in patients undergoing anti-EGFR therapy

#11884
20100150922
2010-06-17

Use of an antibody that blocks TNF-alpha activity for treating a nerve disorder mediated by nucleus pulposus

#11885
20100150915
2010-06-17

METHODS OF TREATING MULTIPLE SCLEROSIS BY ADMINISTRATION OF ALPHA-FETOPROTEIN IN COMBINATION WITH AN INTEGRIN ANTAGONIST

#11886
20100150897
2010-06-17

Compositions and methods for enzymatic treatment of lung disorders

#11887
20100150896
2010-06-17

DIAMINOQUINAZOLINE INHIBITORS OF DIHYDROFOLATE REDUCTASE

#11888
20100150895
2010-06-17

Nutraceutical agent for attenuating the neurodegenerative process associated with Parkinson's disease

#11889
20100150893
2010-06-17

Methods and compositions for treating autoimmune diseases

#11890
20100150888
2010-06-17

Administration of stem or progenitor cells to a joint to enhance recovery from joint surgery

#11891
20100150884
2010-06-17

Anticancer Agent to Be Combined with Telomelysin

#11892
20100150881
2010-06-17

Compositions and Methods for Use of Scar Tissue in Repair of Weight Bearing Surfaces

#11893
20100150867
2010-06-17

Use of α-glucosidase inhibitors to treat alphavirus infections

#11894
20100150865
2010-06-17

NOVEL FORMULATIONS TO INHIBIT CYCLOOXYGENASE AND PRO-INFLAMMATORY CYTOKINE MEDIATED DISEASES

#11895
20100150861
2010-06-17

Compositions with enhanced bioavailability and fast acting inhibitor or gastric acid secretion

#11896
20100150830
2010-06-17

METHOD OF TREATING CANCER

#11897
20100144885
2010-06-10

HISTONE ACETYL TRANSFERASE ACTIVATORS AND HISTONE DEACETYLASE INHIBITORS IN THE TREATMENT OF ALCOHOLISM

#11898
20100144874
2010-06-10

Use of a PPARalpha Agonist and Metformin for Decreasing the Serum Triglycerides

#11899
20100144853
2010-06-10

NOVEL COMBINED ADMINISTRATION

#11900
20100144849
2010-06-10

METHOD FOR INHIBITING SIGNALING MEDIATED BY ErbB2, SIGNALING INHIBITOR TO BE USED THEREFOR AND USE THEREOF

#11901
20100144840
2010-06-10

Methods for modulating the efficacy of nucleic acid based therapies

#11902
20100144811
2010-06-10

Combination of organic compounds useful for treating diabetes

#11903
20100144784
2010-06-10

AEROSOL FORMULATION

#11904
20100144777
2010-06-10

Method of network-based identification of multicomponent synergy and compositions for use as effective component of anti-angiogenesis medicines

#11905
20100144754
2010-06-10

Methods and compositions for treating or preventing narcotic withdrawal symptoms

#11906
20100144753
2010-06-10

Crystal modifications of transmission dyes

#11907
20100144699
2010-06-10

Combination medicaments for treating bacterial infections

#11908
20100144687
2010-06-10

PHARMACEUTICAL COMPOSITIONS CONTAINING TESTOSTERONE AND AN AROMATASE INHIBITOR

#11909
20100144685
2010-06-10

Inhibiting cyclin D polypeptides

#11910
20100144684
2010-06-10

Method of Safely and Effectively Treating and Preventing Secondary Hyperparathyroidism in Chronic Kidney Disease

#11911
20100144683
2010-06-10

METHODS FOR GENERATING MAMMALIAN MODELS OF ATOPIC DISEASES, AND SCREENING FOR THEIR TREATMENT

#11912
20100144660
2010-06-10

USE OF N,N-DIETHYL-2-[-4-(PHENYLMETHYL)-PHENOXY]ETHANAMINE MONOHYDROCHLORIDE (DPPE) IN CANCER THEREAPY

#11913
20100144659
2010-06-10

Targeting agent for cancer cell or cancer-associated fibroblast

#11914
20100144658
2010-06-10

Antibiotics, bispolides A1, A2, and A3 as well as bispolides B1, B2a, B2b and B3 and processes for producing said antibiotics

#11915
20100144652
2010-06-10

COMPOSITION COMPRISING A GLYCOLYTIC INHIBITOR AND A RING SYSTEM COMPRISING A SULPHAMATE GROUP FOR THE TREATMENT OF CANCER

#11916
20100144631
2010-06-10

Concentrated protein preparations of bone morphogenetic proteins and methods of use thereof

#11917
20100144626
2010-06-10

Treatment of Multi-Drug Resistant Bacterial Infections

#11918
20100144624
2010-06-10

Process for the preparation of compositions of AT1 receptor antagonist and Angiotensin—(1-7)

#11919
20100144621
2010-06-10

Use of exendins and exendin agonists and GLP-1 receptor agonists for altering the concentration of fibrinogen

#11920
20100144613
2010-06-10

Combined use of DPP-IV Inhibitors and Gastrin Compounds

#11921
20100144611
2010-06-10

Treatment of T-cell mediated diseases

#11922
20100144606
2010-06-10

COMBINATION 408

#11923
20100144605
2010-06-10

RESCUE OF GONADOTROPIN RELEASING HORMONE RECEPTOR MUTANTS

#11924
20100144604
2010-06-10

Compositions comprising physiologic concentrations of cytokines

#11925
20100144603
2010-06-10

METHODS AND USES THEREOF OF PROSAPOSIN

#11926
20100144602
2010-06-10

Methods of Inhibiting Metastatic Cancer by Administration of Streptolysin O

#11927
20100144598
2010-06-10

Natural polypeptides for oral health care

#11928
20100144597
2010-06-10

Novel combinatorial approaches to enhancing oxygen transport to tissues

#11929
20100144591
2010-06-10

BENZIMIDAZOLE DERIVATIVES AND METHODS OF USE THEREOF

#11930
20100143543
2010-06-10

NUTRITIONAL SUPPLEMENT FORMULATIONS FOR INCLUSION IN FOODS AND FORTIFIED FOODS COMPRISING SUCH SUPPLEMENTS

#11931
20100143507
2010-06-10

CARBOXYLIC ACID INHIBITORS OF HISTONE DEACETYLASE, GABA TRANSAMINASE AND SODIUM CHANNEL

#11932
20100143505
2010-06-10

INDANONE INHIBITORS OF ACETYLCHOLINESTERASE

#11933
20100143504
2010-06-10

Compositions and methods for cardiac tissue protection and regeneration

#11934
20100143503
2010-06-10

COMBINATIONS OF NITRIC OXIDE AND SULFIDE AND METHODS OF USE AND MANUFACTURE THEREOF

#11935
20100143501
2010-06-10

SOLID COMPOSITION COMPRISING A CLAY SUCH AS KAOLIN

#11936
20100143500
2010-06-10

Methods and Compositions for Inhibiting GSK-3 In Glial Cell Related Disorders

#11937
20100143493
2010-06-10

OPHTHALMIC SOLUTIONS

#11938
20100143473
2010-06-10

Combination treatment with strontium for the prophylaxis and/or treatment of cartilage and/or bone conditions

#11939
20100143471
2010-06-10

NOVEL REDUCED DOSE PHARMACEUTICAL COMPOSITIONS OF FEXOFENADINE AND PSEUDOEPHEDRINE

#11940
20100143470
2010-06-10

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING THIAZIDES AND ANGIOTENSIN-II-RECEPTOR BLOCKERS

#11941
20100143469
2010-06-10

Pharmaceutical compositions

#11942
20100143449
2010-06-10

ANALGESIC COMPOSITION OF TOPICALLY APPLIED NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND OPIOIDS

#11943
20100143445
2010-06-10

Dermatological/cosmetic skin depigmenting compositions

#11944
20100143423
2010-06-10

ORAL CARE PRODUCT

#11945
20100143417
2010-06-10

Compositions and methods for controlling diseases in animals

#11946
20100143398
2010-06-10

Synergistic phytoceutical compositions

#11947
20100143397
2010-06-10

Synergistic phytoceutical compositions

#11948
20100143379
2010-06-10

MIF AGONISTS AND ANTAGONIST AND THERAPEUTIC USES THEREOF

#11949
20100143366
2010-06-10

ANTITUMOR AGENT

#11950
20100143355
2010-06-10

Methods for treating pain by administering a nerve growth factor antagonist and an NSAID and compositions containing the same

#11951
20100143352
2010-06-10

COMBINATION THERAPY FOR B CELL DISORDERS

#11952
20100143351
2010-06-10

Anti-Angiogenesis Therapy for the Treatment of Breast Cancer

#11953
20100143350
2010-06-10

Combination of a purine-based CDK inhibitor with a tyrosine kinase inhibitor and use thereof in the treatment of proliferative disorders

#11954
20100143346
2010-06-10

Treatment of Macular Degeneration

#11955
20100143340
2010-06-10

METHODS AND COMPOSITIONS FOR TREATING CANCER

#11956
20100143338
2010-06-10

Treatment of T-cell mediated diseases

#11957
20100143334
2010-06-10

T-140 peptide analogs having CXCR4 super-agonist activity for immunomodulation

#11958
20100143327
2010-06-10

Injection of fibrin sealant including an anesthetic in spinal applications

#11959
20100143325
2010-06-10

Composition And Methods Involving Thrombolytic Agents

#11960
20100143317
2010-06-10

Infarct area perfusion-improving compositions and methods of vascular injury repair

#11961
20100143309
2010-06-10

Viral vectors

#11962
20100143297
2010-06-10

METHODS OF ENHANCING LYSOSOMAL STORAGE DISEASE THERAPY BY MODULATION OF CELL SURFACE RECEPTOR DENSITY

#11963
20100143296
2010-06-10

PODOPHYLLOTOXIN INHIBITORS OF TOPOISOMERASE II

#11964
20100143295
2010-06-10

QUINAZOLINE INHIBITORS OF EGFR TYROSINE KINASE

#11965
20100143293
2010-06-10

T cell activation

#11966
20100143289
2010-06-10

UMBILICAL CORD STEM CELL SECRETED PRODUCT DERIVED TOPICAL COMPOSITIONS AND METHODS OF USE THEREOF

#11967
20100143287
2010-06-10

TRIFLUOROMETHYLPHENYL MODULATORS OF CALCIUM-SENSING RECEPTOR

#11968
20100143285
2010-06-10

Dermatological/pharmaceutical compositions comprising benzoyl peroxide, at least one naphthoic acid compound and at least one polyurethane polymer

#11969
20100143269
2010-06-10

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ASTHMA

#11970
20100143266
2010-06-10

Methods for reducing allergies caused by environmental allergens

#11971
20100143257
2010-06-10

Prevention of Cancers by Immunization

#11972
20100143243
2010-06-10

Frozen compositions and methods for piercing a substrate

#11973
20100137844
2010-06-03

Delivery devices for modulating inflammation

#11974
20100137843
2010-06-03

Delivery devices for modulating inflammation

#11975
20100137816
2010-06-03

Injection of fibrin sealant including an anesthetic in spinal applications

#11976
20100137787
2010-06-03

Delivery devices for modulating inflammation

#11977
20100137583
2010-06-03

Peptidomimetic protease inhibitors

#11978
20100137557
2010-06-03

USE OF ONE OR MORE METAL CARRIERS TO SELECTIVELY KILL MAMMALIAN CELLS

#11979
20100137451
2010-06-03

Compositions and methods for treating hoof diseases

#11980
20100137449
2010-06-03

SUBSTITUTED 1,3-CYCLOPENTADIONE MULTI-TARGET PROTEIN KINASE MODULATORS OF CANCER, ANGIOGENESIS AND THE INFLAMMATORY PATHWAYS ASSOCIATED THEREWITH

#11981
20100137437
2010-06-03

Composition for inactivating an enveloped virus

#11982
20100137434
2010-06-03

Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer

#11983
20100137427
2010-06-03

Softgel of NLKJ for treating prostate diseases

#11984
20100137403
2010-06-03

METHOD FOR ENHANCING COGNITION OR INHIBITING COGNITIVE DECLINE

#11985
20100137399
2010-06-03

PREVENTIVE AND/OR THERAPEUTIC AGENT FOR URINE COLLECTION DISORDER ACCOMPANYING LOWER URINARY TRACT OBSTRUCTION

#11986
20100137392
2010-06-03

Therapy for the treatment of disease

#11987
20100137384
2010-06-03

Anthelmintic composition

#11988
20100137352
2010-06-03

PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS

#11989
20100137348
2010-06-03

Pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-Ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same

#11990
20100137318
2010-06-03

Bicyclic heterocyclic compound

#11991
20100137293
2010-06-03

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

#11992
20100137289
2010-06-03

Methods and Compositions for Ameliorating Thiazide Induced Hyperlipidemia

#11993
20100137284
2010-06-03

Compositions for the Treatment and Prevention of Heart Disease and Methods of Using Same

#11994
20100137271
2010-06-03

PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS

#11995
20100137268
2010-06-03

PHTHALAZINONE MODULATORS OF H1 RECEPTORS AND/OR LTC4 RECEPTORS

#11996
20100137267
2010-06-03

FORMULATIONS FOR TREATMENT OF ADIPOSE TISSUE, CUTANEOUS TISSUE AND DISORDERS, AND MUSCULAR TISSUE

#11997
20100137266
2010-06-03

TREATMENT OF INSULIN RESISTANCE AND DISORDERS ASSOCIATED THEREWITH

#11998
20100137265
2010-06-03

Treatment of conditions relating to hormone deficiencies by administration of progestins

#11999
20100137264
2010-06-03

Progestational 3-(6,6-ethylene-17B-hydroxy-3-oxo-17A-pregna-4-ene-17A-yl)propionic acid G-lactones

#12000
20100137252
2010-06-03

Ophthalmic composition